Wang, Zhao
Liranso, Tesfaye
Maldonado-Cruz, Zulane
Kosheleff, Alisa R.
Nasser, Azmi
Article History
Accepted: 5 March 2024
First Online: 10 April 2024
Declarations
:
: This study and the open access fee were funded and paid for by Supernus Pharmaceuticals, Inc.
: Zhao Wang and Zulane Maldonado-Cruz are employees of Supernus Pharmaceuticals. Tesfaye Liranso, Alisa Kosheleff and Azmi Nasser were employees of Supernus Pharmaceuticals at the time of conduct of the study.
: The data are not available in a repository, but reasonable requests can be directed to the corresponding author (Zhao Wang) at zwang@supernus.com.
: Not applicable.
: This trial was conducted in accordance with the Helsinki Declaration and the International Council for Harmonisation Note for Guidance on Good Clinical Practice. The trial conduct was reviewed and approved by IntegReview IRB (22 September 2017).
: Informed consent was obtained from all individual subjects included in the study.
: Subjects signed informed consent regarding publishing their data.
: Conceptualization: AN, TL. Methodology: AN, TL. Data analysis: ZW, TL, AN, ZM-C. Writing: AK, AN, ZW.